Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Financial Results

Skybiotech Healthcare Financial Results

Skybiotech Healthcare Limited approved its audited standalone and consolidated financial results for the fiscal year ending March 31, 2026. The board meeting concluded with an unmodified audit opinion.

Source

BSE filing, NSE: KAPILCO. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Skybiotech Healthcare Ltd: key numbers

Share price
₹116.00
Market cap
₹22.21 Cr
Revenue (annual)
₹7.10 Cr
Net profit (annual)
₹-1.12 Cr
P/E (TTM)
-13.3×Sector 49.0×
Promoter holding
63.48%+0.00% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Skybiotech Healthcare Ltd

All →

Other financial results announcements

All →